Trial Profile
A Multicentre Cohort Study: Simeprevir and Telaprevir-Based Triple Therapies in patients with Genotype 1B Chronic Hepatitis C Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Telaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 06 Aug 2015 New trial record